January 26, 2023
Splice Bio awarded with a “Colaboración Público-Privada” grant
BARCELONA, January 26, 2023 – SpliceBio, a genetic medicines company on a mission to expand…
February 16, 2022
SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline
Financing co-led by UCB Ventures and Ysios Capital with participation by New Enterprise Associates, Gilde…
December 10, 2020
Splice Bio announces research funding by Cystic Fibrosis Foundation to develop novel AAV vectors
BARCELONA, December 10, 2020 – Splice Bio, a biotech company based on technology developed in…
October 20, 2020
Splice Bio awarded with a “RETOS de Colaboración” grant
BARCELONA, October 20, 2020 – Splice Bio, a biotech company based on technology developed in…
September 15, 2020
ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio
ProteoDesign rebrands as Splice Bio to develop novel gene therapies based on its proprietary intein…
Recent Comments